Pediatric RSV Vaccine Research Should Resume Cautiously US FDA Advisers Say

 
• By Sarah Karlin-Smith
  
baby being provided oxygen
The VRBPAC said more research is needed to determine if additional safety precautions could be taken to mitigate the risk of VAERD with RSV vaccines. (Shutterstock)

More from US Advisory Committees

More from R&D